The HbA1c and blood glucose response to pioglitazone in combination with another antidiabetic agent in patients with type 2 diabetes. - Lebrizzi,R.; Egan,J.W, on behalf of the Pioglitazone 010 014 and 027 Study Groups. (Diabetes, 2000)